Segundo Curso Avanzado sobre Obesidad - page 344

344|José A Gutiérrez Fuentes
16. Aranceta Bartrina J, Serra Majem LL, Foz-­‐Sala M, Moreno Estaban B y grupo
colaborativo SEEDO. Prevalencia de obesidad en España. Med Clin (Barc).
2005;125:460-­‐6.
17. Goday A. Epidemiología de la diabetes y sus complicaciones no coronarias. Rev Esp
Cardiol. 2002;55:657-­‐70.
18.De Pablos Velasco PL, Martínez Martín FJ, Rodríguez Pérez F, Anía BJ, Losada A,
Betancor P. Prevalence and determinants of diabetes mellitus and glucose
intolerance in Canarian Caucasian population ―comparison of the ADA and the
1985 WHO criteria. The Guia Study. Diabet Med. 2001;18:235-­‐41.
19.Martínez-­‐Larrad MT, Fernández-­‐Pérez C, González-­‐Sánchez JL, López A,
Fernández-­‐Álvarez J, Reviriego J, et al. Prevalencia del síndrome metabólico
(criterios ATP-­‐III). Estudio de base poblaciónal en áreas rural y urbana de la
provincia de Segovia. Med Clin (Barc). 2005;125:481-­‐6.
20. Álvarez León EE, Ribas Barba L, Serra Majem L. Prevalencia del síndrome
metabólico en la población de la Comunidad Canaria. Med Clin (Barc).
2003;120:172-­‐4.
21. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon M, Heymsfield SB. The
metabolic syndrome. Prevalence and associated risk factor findings in the US
population from the third National Health a Nutrition Examination Survey, 1988-­‐
1994. Arch Intern Med. 2003;163:427-­‐36.
22. Coppack SW. Pro-­‐inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;
60:349.356.
23. Yamauchi T, Kadowaki T. In: The Metabolic Syndrome at the beginning of the XXIst
Century. Ed: Serrano-­‐Rios M, Caro JF, Carraro R, Gutierrez-­‐Fuentes JA. Elsevier,
2005; 233-­‐252.
24. Lionetti L, Mollica MP, Lombardi A, Cavaliere G, Gifuni G, Barletta A. From chronic
overnutrition to insulin resistance: the role of fat-­‐storing capacity and
inflammation. Nutr Metab Cardiovasc Dis. 2009; 19(2): 146-­‐152.
25.Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis
factor-­‐alpha: direct role in Obesity-­‐linked insulin resistance. Science. 1993; 259:
87-­‐91.
26.Nishimura S, Manabe I, Nagasaki M, Seo K, Yamashita H, Hosoya Y, Ohsugi M, Tobe
K, Kadowaki T, Nagai R, Sugiura S. In vivo imaging in mice reveals local cell
dynamics and inflammation in obese adipose tissue. J Clin Invest. 2008; 118:710-­‐
721.
27.Nathan C. Epidemic inflammation: pondering Obesity. Mol Med. 2008; 14:485-­‐492.
28. Cao Y. Adipose tissue angiogenesis as a therapeutic target for obesity and
metabolic diseases. Nature Rev Drug Discov. 2010; 9:107-­‐115.
1...,334,335,336,337,338,339,340,341,342,343 345,346,347,348,349,350,351,352,353,354,...528
Powered by FlippingBook